Tocilizumab
Administrator2023-03-23T14:20:50+03:00Moderate-severe rheumatoid arthritis used alone or with methotrexate or [...]
Temezolomide
Administrator2023-03-23T15:00:30+03:00Refractory anaplastic astrocytoma: Initially PO 150mg/m2/dose OD on days [...]
Tamoxifen
Administrator2023-03-23T15:04:10+03:00Hormone receptor-positive breast cancer: Adjuvant treatment: PO 20mg OD [...]
Sorafenib
Administrator2023-03-23T15:10:32+03:00Unresectable hepatocellular carcinoma: PO 400mg BD Advanced renal cell [...]
Ruxolitinib
Administrator2023-03-24T15:59:38+03:00Myelofibrosis (intermediate or high-risk): Baseline Pt >200,000: Initially PO [...]
Rituximab
Administrator2023-03-24T16:03:37+03:00CD20-positive Non-Hodgkin’s Lymphoma: In children: Previously untreated, 6 months [...]
Interferon beta 1a
Administrator2023-03-24T16:21:43+03:00Relapsing forms of multiple sclerosis: Initially IM 7.5mcg weekly [...]
Pemetrexed
Administrator2023-03-24T16:46:59+03:00Malignant pleural mesothelioma in patients with unresectable disease or [...]
Pazopanib
Administrator2023-03-24T16:48:31+03:00Advanced renal cell carcinoma: PO 800mg OD Advanced soft [...]
Paclitaxel
Administrator2023-03-24T16:59:24+03:00Advanced ovarian cancer: 1st line treatment: IV 175mg/m² over [...]